XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 685.4 $ 738.4
Marketable investments 875.3 747.5
Accounts receivable, no allowance for 2020 and 2019 172.0 151.4
Inventories, net 89.7 93.4
Other current assets 72.0 133.8
Total current assets 1,894.4 1,864.5
Marketable investments 1,009.4 767.5
Goodwill and other intangible assets, net 158.2 158.3
Property, plant, and equipment, net 744.2 738.5
Deferred tax assets, net 245.8 230.0
Other non-current assets 167.4 154.6
Total assets 4,219.4 3,913.4
Current liabilities:    
Accounts payable and accrued expenses 152.6 148.4
Line of credit (current) 0.0 250.0
Share tracking awards plan 61.0 25.0
Other current liabilities 41.4 39.6
Total current liabilities 255.0 463.0
Line of credit (non-current) 800.0 600.0
Other non-current liabilities 70.7 70.0
Total liabilities 1,125.7 1,133.0
Stockholders’ equity:    
Preferred stock, value issued 0.0 0.0
Common stock, par value $.01, 245,000,000 shares authorized, 70,976,064 and 70,503,775 shares issued, and 44,356,848 and 43,884,559 shares outstanding at June 30, 2020 and December 31, 2019, respectively 0.7 0.7
Additional paid-in capital 2,105.1 2,047.9
Accumulated other comprehensive loss (2.1) (14.2)
Treasury stock, 26,619,216 shares at June 30, 2020 and December 31, 2019 (2,579.2) (2,579.2)
Retained earnings 3,569.2 3,325.2
Total stockholders’ equity 3,093.7 2,780.4
Total liabilities and stockholders’ equity $ 4,219.4 $ 3,913.4